Key result
Caffeine may reduce SIDS risk by enhancing respiratory stability and arousal capacity against hypoxia.
Why the study?
Intermittent hypoxia may be the primary mechanism driving SIDS, and whether caffeine can serve as a protective intervention to reduce SIDS risk required evaluation.
Does caffeine prevent Sudden Infant Death Syndrome (SIDS) in infants?
Does caffeine prevent Sudden Infant Death Syndrome (SIDS) in infants?
This perspective proposes the hypothesis that caffeine may reduce the risk of SIDS by mitigating the effects of intermittent hypoxia.
Answers are grounded in this paper and cite their sources.
No change to SIDS prevention practice warranted; leaves open hypothesis for randomized trials.
This review proposes that intermittent hypoxia is the primary pathogenic mechanism driving Sudden Infant Death Syndrome (SIDS). Intermittent hypoxia is a powerful source of molecular and cellular injury and is frequently experienced by infants, especially under conditions associated with known SIDS risk factors such as prone sleeping, respiratory infections, and prenatal nicotine exposure. These factors often trigger hypoxic episodes that may impair autonomic regulation, hinder arousal from sleep, and damage critical neural circuits. By integrating current data, this review highlights the central role of intermittent hypoxia in SIDS pathophysiology. Additionally, it evaluates the potential of caffeine, a respiratory stimulant and adenosine receptor antagonist, as a protective intervention to reduce SIDS risk by enhancing respiratory stability and arousal capacity.
No takes yet. Share an insight, caveat, or question.
Hegyi et al. (2025) conducted a review in Sudden Infant Death Syndrome (SIDS). Caffeine was evaluated. Caffeine is proposed as a potential protective intervention to reduce the risk of Sudden Infant Death Syndrome by enhancing respiratory stability and arousal capacity against intermittent hypoxia.
Synapse has enriched 10 related papers. Consider them for comparative context: